Symposium on 'nutritional aspects of bone': Markers of bone turnover in relation to bone health

Proceedings of the Nutrition Society

Volumn 56, Issue 3, 1997, Pages 903-914

  Robins, Simon P ^a   New, Susan A ^b  

^a ROWETT RESEARCH INSTITUTE   (United Kingdom)

^b UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; ESTROGEN; TRACE ELEMENT;

BONE; BONE REMODELING; HUMAN; NUTRITION; PHYSIOLOGY; REVIEW;

BIOLOGICAL MARKERS; BONE AND BONES; BONE REMODELING; ESTROGENS; HUMANS; MICRONUTRIENTS; NUTRITION PHYSIOLOGY;

EID: 0031263953     PISSN: 00296651     EISSN: None     Source Type: Journal    
DOI: 10.1079/pns19970098     Document Type: Conference Paper

References (79)

1. Abbiati, G., Bartucci, F., Longoni, A., Fincato, G., Galimberti, S., Rigoldi, M. & Castiglioni, C. (1993). Monitoring of free and total urinary pyridinoline and deoxypyridinoline in healthy volunteers: sample relationships between 24-h and fasting early morning urine concentrations. Bone and Mineral 21, 9-19.
2. Alvarez, L., Guanabens, N., Peris, P., Monegal, A., Bedini, J., Deulofeu, R., Martinez de Osaba, J. M., Munoz, G.-J., Rivera-Fillat, F. & Ballesta, A. M. (1995). Discriminative value of biochemical markers of bone turnover in assessing the activity of Paget's disease. Journal of Bone and Mineral Research 10, 458-465.
3. Arnett, T. R. & Dempster, D. W. (1986). Effect of pH on bone resorption by rat osteoclasts in vitro. Endocrinology 119, 119-124.
4. Barger-Lux, M. J. & Heaney, R. P. (1993). Effects of calcium restriction on metabolic characteristics of premenopausal women. Journal of Clinical Endocrinology and Metabolism 76, 103-107.
5. Bettica, P., Moro, L., Robins, S. P., Taylor, A. K., Talbot, J., Singer, F. R. & Baylink, D. J. (1992). The comparative performance of urinary bone resorption markers: galactosyl hydroxylysine, pyridinium crosslinks, hydroxyproline. Clinical Chemistry 38, 2313-2318.
6. Bienkowski, R. (1984). Intracellular degradation of newly synthesized collagen. Collagen and Related Research 4, 399-412.
7. Black, D., Duncan, A. & Robins, S. P. (1988). Quantitative analysis of the pyridinium crosslinks of collagen in urine using ion-paired reversed-phase high-performance liquid chromatography. Analytical Biochemistry 169, 197-203.
8. Bonde, M., Qvist, P., Fledelius, C., Riis, B. & Christiansen, C. (1994). Immunoassay for quantifying type I degradation products in urine evaluated. Clinical Chemistry 40, 2022-2025.
9. Booth, S. L., Sokoll, L. J., O'Brien, M. E., Tucker, K., Dawson-Hughes, B. & Sadowski, J. A. (1995). Assessment of dietary phylloquinone intake and vitamin K status in postmenopausal women. European Journal of Clinical Nutrition 49, 832-841.
10. Bushinsky, D. A. & Sessler, N. E. (1992). Critical role of bicarbonate in calcium release from bone. American Journal of Physiology 263, F510-F515.
11. Calvo, M. S., Kumar, R. & Heath, H. (1988). Elevated secretion and action of serum parathyroid hormone in young adults consuming high phosphorus, low calcium diets assembled from common foods. Journal of Clinical Endocrinology and Metabolism 66, 823-829.
12. Calvo, M. S., Kumar, R. & Heath, H. (1990). Persistently elevated parathyroid hormone secretion and action in young women after four weeks of ingesting high phosphorous, low calcium diets. Journal of Clinical Endocrinology and Metabolism 70, 1334-1340.
13. Chan, E., Ho, C., MacDonald, D., Ho, S. & Chan, R. (1992). Interrelationships between urinary sodium, calcium, hydroxyproline and serum PTH in healthy subjects. Acta Endocrinologica 127, 242-245.
14. Chan, A., Poon, P., Chan, E., Fung, S. & Swaminathan, R. (1993). The effect of high sodium intake on bone mineral content in rats fed a normal calcium or low calcium diet. Osteoporosis International 3, 341-344.
15. Colwell, A., Russell, R. & Eastell, R. (1993). Factors affecting the assay of urinary 3-hydroxy pyridinium crosslinks of collagen as markers of bone resorption. European Journal of Clinical Investigation 23, 341-349.
16. Consensus Development Conference (1993). Diagnosis, prophylaxis and treatment of osteoporosis. American Journal of Medicine 94, 646-650.
17. Delmas, P., Christiansen, C., Mann, K. & Price, P. (1990). Bone Gla protein (osteocalcin): assay standardization report. Journal of Bone and Mineral Research 5, 5-11.
18. Delmas, P., Schlemmer, A., Gineyts, E., Riis, B. & Christiansen, C. (1991). Urinary excretion of pyridinoline crosslinks correlates with bone turnover measured on iliac crest biopsy in patients with vertebral osteoporosis. Journal of Bone and Mineral Research 6, 639-644.
19. Douglas, A., Robins, S. P., Hutchison, J., Porter, R., Stewart, A. & Reid, D. M. (1995). Carboxylation of osteocalcin in post-menopausal osteoporotic women following vitamin K and D supplementation. Bone 17, 15-20.
20. Driessens, F., Verbeeck, R., van Dijk, J. & Borggreven, J. (1987). Response of plasma calcium and phosphate to magnesium depletion. A review and its physiological interpretation. Magnesium Bulletin 9, 193-201.
21. Ducy, P., Desbois, C., Boyce, B., Pinero, G., Story, B., Dunstan, C., Smith, E., Bonadio, J., Goldstein, S., Gundberg, C., Bradley, A. & Karsenty, G. (1996). Increased bone formation in osteocalcin-deficient mice. Nature 382, 448-452.
22. Eastell, R., Colwell, A., Hampton, L. & Reeve, J. (1997). Biochemical markers of bone resorption compared with estimates of bone resorption from radiotracer kinetic studies in osteoporosis. Journal of Bone and Mineral Research 12, 59-65.
23. Fledelius, C., Johnsen, A., Cloos, P., Bonde, M. & Qvist, P. (1997). Characterization of urinary degradation products derived from type I collagen. Journal of Biological Chemistry 272, 9755-9763.
24. Garnero, P. & Delmas, P. (1993). Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic bone disease. Journal of Clinical Endocrinology and Metabolism 77, 1046-1053.
25. Garnero, P., Grimaux, M., Demiaux, B., Preaudat, C., Seguin, P. & Delmas, P. D. (1992). Measurement of serum osteocalcin with a human-specific 2-site immunoradiometric assay. Journal of Bone and Mineral Research 7, 1389-1398.
26. Garnero, P., Hausherr, E., Chapuy, M., Marcelli, C., Grandjean, H., Muller, C., Cormier, C., Breart, G., Meunier, P. & Delmas, P. (1996). Markers of bone resorption predict hip fracture in elderly women: The EPIDOS prospective study. Journal of Bone and Mineral Research 11, 1531-1538.
27. Gomez, B., Ardakani, S., Ju, J., Jenkins, D., Cerelli, M., Daniloff, G. & Kung, V. (1995). Monoclonal antibody assay for measuring bone-specific alkaline phosphatase activity in serum. Clinical Chemistry 41, 1560-1566.
28. Hannon, R., Blumsohn, A., Al-Dehaimi, A. & Eastell, R. (1995). The use of biochemical markers of bone turnover to monitor the skeletal response to hormone replacement therapy. Bone 16, Suppl. 1, 109S.
29. Hanson, D., Weis, M., Bollen, A., Maslan, S., Singer, F. & Eyre, D. (1992). A specific immunoassay for monitoring human bone resorption: quantitation of type I collagen cross-linked N-telopeptides in urine. Journal of Bone and Mineral Research 7, 1251-1258.
30. Hassager, C., Jensen, L., Johansen, J., Riis, B., Melkko, J., Podenphant, J., Risteli, L., Christiansen, C. & Risteli, J. (1991). The carboxy-terminal propeptide of type I procollagen in serum as a marker of bone formation: the effect of nandrolone decanoate and female sex hormones. Metabolism 40, 205-208.
31. Hassager, C., Risteli, J., Risteli, L., Jensen, S. & Christiansen, C. (1992). Diurnal variation in serum markers of type I collagen synthesis and degradation in healthy premenopausal women. Journal of Bone and Mineral Research 7, 1307-1311.
32. Heaney, R. P. (1993). Nutritional factors in osteoporosis. Annual Review of Nutrition 13, 287-316.
33. Heaney, R. P. & Recker, R. R. (1982). Effects of nitrogen, phosphorus and caffeine on calcium balance in women. Journal of Laboratory and Clinical Medicine 99, 46-55.
34. Hodges, S. J., Akesson, K., Vergnaud, P., Obrant, K. & Delmas, P. D. (1993). Circulating levels of vitamins K1 and K2 decreased in elderly women with hip fracture. Journal of Bone and Mineral Research 8, 1241-1245.
35. Hodges, S. J., Pilkington, M. J., Shearer, M. J., Bitensky, L. & Chayen, J. (1990). Age-related changes in the circulating levels of congeners of vitamin K2, menaquinone-7 and menaquinone-8. Clinical Science 78, 63-66.
36. Knapen, M. H. J., Hamulyak, K. & Vermeer, C. (1989). The effect of vitamin K supplementation on circulating osteocalcin (bone gla protein) and urinary calcium excretion. Annals of Internal Medicine 111, 1001-1005.
37. Knight, D. C. & Eden, J. A. (1995). Phytoestrogens - a short review. Maturitas 22, 167-175.
38. Krane, S., Kantrowitz, F., Byrne, M., Pinell, S. & Singer, F. (1977). Urinary excretion of hydroxylysine and its glycosides as an index of collagen degradation. Journal of Clinical Investigation 59, 819-827.
39. Krieger, N. S., Sessler, N. E. & Bushinsky, D. A. (1992). Acidosis inhibits osteoblastic and stimulates osteoclastic activity in vitro. American Journal of Physiology 262, F442-F448.
40. Lemann, J. Jr, Gray, R. W. & Pleuss, J. A. (1989). Potassium bicarbonate, but not sodium bicarbonate, reduces urinary calcium excretion and improves calcium balance in healthy men. Kidney International 35, 688-695.
41. Lemann, J. Jr, Pleuss, J. A. & Gray, R. W. (1993). Potassium causes calcium retention in healthy adults. Journal of Nutrition 123, 1623-1626.
42. Lemann, J. Jr, Pleuss, J. A., Gray, R. W. & Hoffmann, R. G. (1991). Potassium administration reduces and potassium deprivation increases urinary calcium excretion in healthy adults. Kidney International 39, 973-983.
43. Lietz, G., Avenell, A. & Robins, S. P. (1997). Short-term effects of dietary sodium intake on bone metabolism in postmenopausal women measured using urinary deoxypyridinoline excretion. British Journal of Nutrition 78, 73-82.
44. McKane, W., Khosla, S., Risteli, J., Robins, S. P., Muhs, J. & Riggs, B. (1997). Role of estrogen deficiency in pathogenesis of secondary hyperparathyroidism and increased bone resorption in elderly women. Proceedings of the Association of American Physicians 109, 174-180.
45. Melkko, J., Kauppila, S., Niemi, S., Risteli, L., Haukipuro, K., Jukkola, A. & Risteli, J. (1996). Immunoassay for intact amino-terminal propeptide of human type I procollagen. Clinical Chemistry 42, 947-954.
46. Melkko, J., Niemi, S., Risteli, L. & Risteli, J. (1990). Radioimmunoassay of the carboxyterminal propeptide of human type I procollagen. Clinical Chemistry 36, 1328-1332.
47. Merle, B. & Delmas, P. D. (1990). Normal carboxylation of circulating osteocalcin (bone gla protein) in Paget's disease of bone. Bone and Mineral 11, 237-245.
48. Michaelsson, K., Holmberg, L., Mallmin, H., Wolk, A., Bergstrom, R. & Ljunghall, S. (1995). Diet, bone mass, and osteocalcin: A cross-sectional study. Calcified Tissue International 57, 86-93.
49. Moro, L., Modricky, C., Rovis, L. & DeBernard, B. (1988). Determination of galactosyl hydroxylysine in urine as a means for the identification of osteoporotic women. Bone and Mineral 3, 271-276.
50. Need, A. G., Morris, H. A., Cleghorn, D. B., Nichilo, D. D., Horowitz, M. & Nordin, B. E. C. (1991). Effect of salt restriction on urinary hydroxyproline excretion in postmenopausal women. Archives of Internal Medicine 151, 757-759.
51. New, S. A. (1995). An epidemiological investigation into the influence of nutritional factors on bone mineral density and bone metabolism. PhD Thesis, University of Aberdeen.
52. New, S. A., Robins, S. P., Garton, M., Martin, J., Grubb, D., Bolton-Smith, C., Lee, S. & Reid, D. M. (1996). Effects of dietary and non-dietary factors on bone metabolism. Proceedings of the Nutrition Society 55, 12A.
53. Orum, O., Hansen, M., Jensen, C., Sorensen, H., Jensen, L., Horslev-Petersen, K. & Teisner, B (1996). Procollagen type I N-terminal propeptide (PINP) as an indicator of type I collagen metabolism: ELISA development, reference interval, and hypovitaminosis D induced hyperparathyroidism. Bone 19, 157-163.
54. Parfitt, A. M., Mundy, G. R., Roodman, G. D., Hughes, D. F. & Boyce, B. F. (1996). A new model for the regulation of bone resorption with particular reference to the effects of bisphosphonates. Journal of Bone and Mineral Research 11, 150-159.
55. Pratt, D. A., Daniloff, Y., Duncan, A. & Robins, S. P. (1992). Automated analysis of the pyridinium crosslinks of collagen in tissue and urine using solid-phase extraction and reversed-phase high-performance liquid chromatography. Analytical Biochemistry 207, 168-175.
56. Price, C. (1993). Multiple forms of human serum alkaline phosphatase: detection and quantitation. Annals of Clinical Biochemistry 30, 355-372.
57. Price, P. A. & Nishimoto, S. K. (1980). Radioimmunoassay for the vitamin K-dependent protein of bone and its discovery in plasma. Proceedings of the National Academy of Sciences USA 77, 2234-2238.
58. Price, R., Fenton, S., Shearer, M. & Bolton-Smith, C. (1996). Daily and seasonal variation in phylloquinone (vitamin K1) intake in Scotland. Proceedings of the Nutrition Society 55, 244A.
59. Risteli, J., Niemi, S., Kauppila, S., Melkko, J. & Risteli, L. (1995). Collagen propeptides as indicators of collagen assembly. Acta Orthopaedica Scandinavica 266, Suppl., 183-188.
60. Risteli, L. & Risteli, J. (1993). Biochemical markers of bone metabolism. Annals of Medicine 25, 385-393.
61. Risteli, L., Risteli, J. & Moniz, C. (1993). Measuring collagen degradation. European Journal of Clinical Investigation 23, 339-340.
62. Robins, S. P. (1982). Turnover and crosslinking of collagen. In Collagen in Health and Disease, pp. 160-178 [J. B. Weiss and M. I. V. Jayson, editors]. Edinburgh: Churchill Livingstone.
63. Robins, S. P. (1995). Collagen crosslinks in metabolic bone disease. Acta Orthopaedica Scandinavica 266, Suppl., 171-175.
64. Robins, S. P., Black, D., Paterson, C. R., Reid, D. M., Duncan, A. & Seibel, M. J. (1991). Evaluation of urinary hydroxypyridinium crosslink measurements as resorption markers in metabolic bone diseases. European Journal of Clinical Investigation 21, 310-315.
65. Robins, S. P., Duncan, A. & Riggs, B. L. (1990). Direct measurement of free hydroxypyridinium crosslinks of collagen in urine as new markers of bone resorption in osteoporosis. In Osteoporosis 1990, pp. 465-468 [C. Christiansen and K. Overgaard, editors]. Copenhagen: Osteopress ApS.
66. Robins, S. P., Hamilton, N., Nicol, P., Boschitsch, E., Endler, T. & Seibel, M. J. (1994a). Bone resorption rates in pre-, peri-, and post-menopausal women determined by direct immunoassay of deoxypyridinoline. Journal of Bone and Mineral Research 9, S278.
67. Robins, S. P., Woitge, H., Hesley, R., Ju, J., Seyedin, S. & Seibel, M. J. (1994b). Direct, enzyme-linked immunoassay for urinary deoxypyridinoline as a specific marker for measuring bone resorption. Journal of Bone and Mineral Research 9, 1643-1649.
68. Schwartz, R. & Reddi, A. (1979). Influence of magnesium depletion on matrix-induced endochondral bone formation. Calcified Tissue International 29, 15-20.
69. Sebastian, A., Harris, S. T., Ottaway, J. H., Todd, K. M. & Morris, R. C. Jr (1994). Improved mineral balance and skeletal metabolism in postmenopausal women treated with potassium bicarbonate. New England Journal of Medicine 330, 1776-1781.
70. Seibel, M. J., Robins, S. P. & Bilezikian, J. P. (1992). Urinary pyridinium crosslinks of collagen: specific markers of bone resorption in metabolic bone disease. Trends in Endocrinology and Metabolism 3, 263-270.
71. Seyedin, S., Kung, V., Daniloff, Y., Hesley, R., Gomez, B., Nielsen, L., Rosen, H. & Zuk, R. (1993). Immunoassay for urinary pyridinoline: the new marker of bone resorption. Journal of Bone and Mineral Research 8, 635-641.
72. Shortt, C. & Flynn, A. (1990). Sodium-calcium inter-relationships with specific reference to osteoporosis. Nutrition Research Reviews 3, 101-115.
73. Szulc, P., Chapuy, M. C., Meunier, P. J. & Delmas, P. D. (1993). Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women. Journal of Clinical Investigation 91, 1769-1774.
74. Teti, A., Blair, H. C., Schlesinger, P., Grano, M., Zambonin-Zallone, A., Kahn, A. J., Teitelbaum, S. L. & Hruska, K. A. (1989). Extracellular protons acidify osteoclasts, reduce cytosolic calcium, and promote expression of cell-matrix attachment structures. Journal of Clinical Investigation 84, 773-780.
75. Thomas, A. (1988). Osteoporosis. Lancet i, 1002.
76. Trimmer, E. (1988). Osteoporosis. Lancet i, 177.
77. Van Daele, P., Seibel, M. J., Burger, H., Hofman, A., Grobbee, D., van Leeuwen, J., Birkenhaeger, J. & Pols, H. (1996). Case-control analysis of bone resorption markers, disability and hip fracture risk: the Rotterdam study. British Medical Journal 312, 482-483.
78. Vergnaud, P., Garnero, P., Meunier, P. J., Breart, G., Kamihagi, K. & Delmas, P. D. (1997). Undercarboxylated osteocalcin measured with a specific immunoassay predicts hip fracture in elderly women: the EPIDOS study. Journal of Clinical Endocrinology and Metabolism 82, 719-724.
79. World Health Organization (1994). Assessment of fracture risk and its application to screening for osteoporosis. Technical Report Series no. 843. Geneva: WHO.